CLYM Return on Tangible Equity | CLIMB BIO, INC.

CLIMB BIO, INC. (CLYM) Return on Tangible Equity

2026-06-30: Return Tang Equity -24.06%.
2026-03-31: Return Tang Equity -35.65%.
2025-12-31: Return Tang Equity -37.30%.
2025-09-30: Return Tang Equity -28.67%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-24.06%
2026-03-31	-35.65%
2025-12-31	-37.30%
2025-09-30	-28.67%
2025-06-30	-25.17%
2025-03-31	-48.08%
2024-12-31	-34.88%
2024-09-30	-31.59%
2024-06-30	-28.88%
2024-03-31	-13.65%
2023-12-31	-32.64%
2023-09-30	-35.76%
2023-06-30	-39.96%
2023-03-31	-46.49%
2022-12-31	-35.15%
2022-09-30	-35.75%
2022-06-30	-33.72%
2022-03-31	-27.13%
2021-12-31	-28.40%
2021-09-30	-29.32%
2021-06-30	87.40%
2021-03-31	86.50%
2020-12-31	82.73%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-37.30%
2024-12-31	-34.88%
2023-12-31	-32.64%
2022-12-31	-35.15%
2021-12-31	-28.40%
2020-12-31	82.73%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
IRONWOOD PHARMACEUTICALS INC (IRWD)	United States	$0.694B	5.37
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61
Nuvectis Pharma, Inc. (NVCT)	United States	$0.705B	-17.53
Verastem, Inc. (VSTM)	United States	$0.706B	-1.71
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
COLLEGIUM PHARMACEUTICAL, INC (COLL)	United States	$0.737B	24.57
Neurogene Inc. (NGNE)		$0.625B	-4.46
Faeth Therapeutics, Inc. (FTH)	United States	$0.750B
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47